IP Library Granted Patent US 11,884,916
Granted Patent B2
US 11,884,916 · App. 16/920,204 · Granted Jan 30, 2024

Materials and methods for the synthesis of error-minimized nucleic acid molecules

Inventors: Daniel G Gibson (Carlsbad, CA); Nicky Caiazza (Rancho Santa Fe, CA); Toby H. Richardson (San Diego, CA)
Assignee: Telesis Bio Inc.
C12N15/1093C12N9/22C12P19/34C12Q1/6844C12Y301/11C12Y301/21C07K2319/00C07K2319/02C07K2319/036
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,884,916
App. No.
16/920,204
Granted
Jan 30, 2024
Kind
B2
Abstract

The present invention provides materials and methods useful for error correction of nucleic acid molecules. In one embodiment of the invention, a first plurality of double-stranded nucleic acid molecules having a nucleotide mismatch are fragmented by exposure to a molecule having unidirectional mismatch endonuclease activity. The nucleic acid molecules are cut at the mismatch site or near the mismatch site, leaving a double-stranded nucleic acid molecule having a mismatch at the end or near end of the molecule. The nucleic acid molecule is then exposed to a molecule having unidirectional exonuclease activity to remove the mismatched nucleotide. The missing nucleotides can then be filled in by the action of, e.g., a molecule having DNA polymerase activity. The result is double-stranded nucleic acid molecules with a decreased frequency of nucleotide mismatches. Also provided are novel nucleic acid sequences encoding mismatch endonucleases, polypeptides encoded thereby, as well as nucleic acid constructs, transgenic cells, and various compositions thereof.

Claims (12)

1. A composition comprising: (i) a molecule having a unidirectional mismatch endonuclease activity having at least 80% sequence identity to a sequence selected from the group consisting of: SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 21, SEQ ID NO: 23, SEQ ID NO: 25, SEQ ID NO: 27, SEQ ID NO: 28, and SEQ ID NO: 29, and (ii) a molecule having unidirectional exonuclease activity of the same directionality as the unidirectional mismatch endonuclease activity of (i).

2. A composition according to claim 1 , wherein the molecule of (ii) is selected from the group consisting of exonuclease III, a DNA polymerase, and a combination of exonuclease III and a DNA polymerase.

3. A composition according to claim 2 , wherein the molecule of (ii) is selected from the group consisting of exonuclease III.

4. The composition of claim 1 , wherein the molecule having a unidirectional mismatch endonuclease activity has at least 90% sequence identity to a sequence selected from the group consisting of: SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 21, SEQ ID NO: 23, SEQ ID NO: 25, SEQ ID NO: 27, SEQ ID NO: 28, and SEQ ID NO: 29.

5. The composition according to claim 4 , wherein the molecule of (ii) is selected from the group consisting of exonuclease III, a DNA polymerase, and a combination of exonuclease III and a DNA polymerase.

6. The composition according to claim 4 wherein the molecule of (ii) is exonuclease III.

7. A kit comprising a composition according to claim 1 .

8. A kit comprising a composition according to claim 2 .

9. A kit comprising a composition according to claim 3 .

10. A kit comprising a composition according to claim 4 .

11. A kit comprising a composition according to claim 5 .

12. A kit comprising a composition according to claim 6 .

Assignments (8)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (TERM) Recorded Jul 16, 2024
From: MIDCAP FINANCIAL TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0070 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (REVOLVING) Recorded Jul 16, 2024
From: MIDCAP FUNDING IV TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0001 →
CHANGE OF NAME Recorded Jun 14, 2023
From: SGI-DNA, INC.
To: CODEX DNA, INC.
Reel/Frame 063992/0418 →
CHANGE OF NAME Recorded Jun 14, 2023
From: CODEX DNA, INC.
To: TELESIS BIO INC.
Reel/Frame 063992/0678 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2023
From: GIBSON, DANIEL G.; CAIAZZA, NICKY C.; RICHARDSON, TOBY H.
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 063952/0992 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2023
From: SYNTHETIC GENOMICS, INC.
To: SGI-DNA, INC.
Reel/Frame 063953/0103 →
SECURITY INTEREST (TERM) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061208/0080 →
SECURITY INTEREST (REVOLVING) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 061208/0063 →
Continuity (4)
Continuation 15667515 · Aug 2, 2017
Division 13757633 · Feb 1, 2013
Provisional Application 61593813 · Feb 1, 2012
Related Publication 20200332286A1 · Oct 22, 2020